WNT16 and osteoporosis: To evaluate WNT16 as a possible osteoporosis drug target, one has to consider not only osteoblast-derived WNT16 but also global WNT16 expression that may exert off target side effects, arguing for the use of an inducible global Wnt16 inactivation mouse model in the present study.